2062 POSTER Comparison of the cost-effectiveness of upfront letrozole or anastrozole, or switched exemestane versus tamoxifen for early breast cancer in hormone receptor positive (HR+) postmenopausal women: the UK perspective

✍ Scribed by F. Di Trapani; J. Karnon; S. Kaura

• Book ID: 118625666
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 79 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70824-8